论文部分内容阅读
目的 评估非小细胞肺癌临床分期的准确性 ,探讨临床分期中边缘性可切除的患者的外科治疗策略。方法 回顾分析 2 15例非小细胞肺癌患者的临床分期和外科病理分期资料。结果 10 2例(4 7.4 % )患者的临床分期与外科病理分期相符合。临床肿瘤 (T)和淋巴结 (N)分期的准确率分别为 70 .7%和 4 9.3%。结论 非小细胞肺癌的术前临床分期仍然是粗略的评估。有必要采用纵隔镜检查术行肺癌的术前病理分期。对于cT4N0 / 1患者 ,经过谨慎选择后 ,仍应给予手术机会。
Objective To evaluate the accuracy of clinical staging of non-small cell lung cancer (NSCLC) and to explore the surgical treatment strategy of marginal resectable patients in clinical staging. Methods Retrospective analysis of 2 15 cases of non-small cell lung cancer patients with clinical stage and surgical pathological staging data. Results The clinical stage of 102 patients (7.4%) was consistent with the surgical pathological stage. The accuracy rates of clinical tumor (T) and lymph node (N) staging were 70.7% and 49.3% respectively. Conclusion Preoperative clinical stage of non-small cell lung cancer is still a rough estimate. It is necessary to use preoperative mediastinoscopy lung cancer preoperative pathological staging. For cT4N0 / 1 patients, after careful choice, surgery should still be given.